Research Article
Validation of the Model of End-Stage Liver Disease for Liver Transplant Allocation in Alberta: Implications for Future Directions in Canada
Table 3
The distribution of patients and overall mortality rates within MELD strata, CP classes and CanWAIT.
(a) |
| MELD | | % Total | Deaths | % Mortality |
| <10 | 92 | 28.8% | 7 | 7.6% | 10–19 | 160 | 50% | 22 | 13.8% | 20–29 | 46 | 14.4% | 11 | 23.9% | 30–39 | 15 | 4.7% | 7 | 46.7% | ≥40 | 7 | 2.2% | 2 | 28.6% |
|
|
(b) |
| CP class | | % Total | Deaths | % Mortality |
| A (5-6) | 32 | 10% | 3 | 9.4% | B (7–9) | 145 | 45.3% | 10 | 6.9% | C (10–15) | 143 | 44.7% | 36 | 25.2% |
|
|
(c) |
| CanWAIT status | | % Total | Deaths | % Mortality |
| 0 | 105 | 32.8% | 15 | 14.3% | 1 | 146 | 45.6% | 20 | 13.7% | 1T | 9 | 2.8% | 2 | 22.2% | 2 | 43 | 13.4% | 7 | 16.3% | 3 | 4 | 1.3% | 1 | 25% | 3F | 1 | 0.3% | 0 | 0% | 4 | 4 | 1.3% | 2 | 50% | 4F | 8 | 2.5% | 2 | 25% |
|
|